Techniques which estimate the rate of aqueous flow generally require the use of tracer substances. Determination of the distribution of the tracer in the relevant body compartments permits calculation of the rate of flow within the limits of accuracy of the method used. The underlying theory, as well as the advantages and limitations of methods employing systemic, topical, intracameral, and intravitreal administration of tracer substances are reviewed. Since these methods all assume that the rate of aqueous secretion is constant, yet the presence of a diurnal rhythm of flow has been demonstrated in both rabbits and humans, a compartmental model of a circadian system based upon the vitreous depot technique is presented. This model estimates the degree to which a continuously changing rate of aqueous flow limits the ability to determine aqueous flow rate accurately by this particular method and illustrates this limitation, which is common to all tracer methods.
constant during the course of the experiment. The test substance is initially absent from the aqueous, but its concentration increases over time until it reaches a steady-state concentration, Cam, which is determined by the concentration in the plasma, the rate of aqueous flow, and the ability of the tracer to diffuse from plasma into aqueous. By measuring Cax. and the rate at which the concentration of tracer approaches this steady-state level, the rate of aqueous flow can be determined.
In a study of the steady-state distribution of various solutes between the blood and aqueous, Kinsey and Grant [1] presented the mathematical derivation of the equations upon which these methods are based. This derivation as adapted by Becker [2] argues that, if the tracer enters the aqueous strictly by diffusion and mixes completely with the aqueous, the rate of change of concentration of tracer in the aqueous can be expressed: dC dt= kd(Cp-CaY-kfCa [1] where kd = the coefficient of diffusion exchange of tracer between aqueous and plasma kf = the coefficient of escape of tracer from anterior chamber by bulk flow of aqueous Cp = the concentration of tracer in the plasma, which remains constant C, = the concentration of tracer in the aqueous humor If ko = kd+ kf then equation 1 [3] CP Substituting into equation 2: dCa dt = ko(Ca. -Ca) [4] and, by integration:
Ca -Ca =Ca e-k [5] ln (Ca. -Ca) = ln (Ca.) -kot [6] Experimental determination of Ca at at least one point in time, and Ca. after reaching the steady state, permits the calculation of k,. By substitution into equation 3 and from the measured value of C,, the value of kf can be determined.
If the tracer enters the aqueous solely by secretion, and therefore can leave the eye only by bulk flow, where ks is the coefficient of secretion of tracer into aqueous from the blood, equation 1 simplifies to: dCa dt sp kja [7] and an analogous derivation leads to: ln (Ca. -Ca) = ln (Cax,) -kft [8] In this case, kf can be determined directly from values for Ca,. and Ca.
The relationship between the first-order rate constant for exit of tracer by bulk flow kf and the rate of aqueous flow can be shown by the following simple derivation.
Assuming that the tracer can exit only by bulk flow, the rate of change of mass of tracer in the anterior chamber can be expressed: dm t =-a * f [9] where m = the mass of tracer in the anterior chamber Ca = the concentration of tracer in the aqueous f = the rate of aqueous flow But since m = C, VI where Va is the volume of the anterior chamber, substituting and rearranging, equation 9 becomes: dCa -f Ca =-dt [10] C, VI Integrating equation 10 we get:
C. = CO ekf [11] where C0 is the initial concentration of tracer in the aqueous, and f kf = [12] demonstrating that kf represents the fractional rate of turnover of aqueous in the anterior chamber per unit of time. This technique has been employed, using several different tracer substances, by various investigators. For example, Goldmann [3] and Nagataki [4] each used intravenous fluorescein to measure aqueous flow in humans relative to the volume of the anterior chamber and obtained mean rates of 1.1 percent + 0.2 percent and 0.974 percent + 0.094 percent per minute, respectively. This technique had the advantage of allowing the measurement to be made without removing aqueous from the eye, but still required several blood samples. Becker [2] administered radioactive isotopes of iodine to rabbits by a combination of intraperitoneal and intravenous injection and continuous intravenous infusion. Using two different isotopes administered at different times before sampling the aqueous permitted a single aqueous sample to provide both data points required for the measurement. With this technique he found a relative rate of aqueous flow per minute of 1.5 percent t 0.17 percent of the volume of the anterior chamber.
In an attempt to alleviate the difficulties associated with maintaining constant plasma tracer levels, Bairainy and Kinsey [5, 6] Bairainy and Kinsey [5, 6] tried to overcome by using systemic tracers that are rapidly eliminated from the blood. It does so, however, at the expense of a directly invasive procedure which may affect the normal physiology of the eye during the course of the experiment. Tracers used by investigators employing this method have included radioactively iodinated albumin [7, 8] , iodoantipyrene [9] , iodohippurate [9] , blue dextran [10] , and fluorescein isothiocyanate-(FITC-) dextran [11] .
DILUTION METHODS Another group of methods to measure aqueous flow is based upon the dilution of a tracer during continuous perfusion with a buffer solution containing tracer [12, 13] . Through a cannula placed in the anterior or posterior chamber, the buffer is infused at a constant rate, where it is assumed to mix completely with newly forming aqueous. The degree of dilution of the tracer substance is related to the rate of aqueous humor formation. Aqueous leaves the eye through the normal outflow channels and through another cannula in the anterior chamber from which aqueous tracer concentration measurements can be made. The height of the fluid column attached to this cannula is adjusted to maintain IOP at its initial level. Since after reaching a steady state the rate of entry and exit of tracer must be equal, rp Cp =(rp + f)Ca f=rFp (C, -C.) [14] As the rate of perfusion and concentration of tracer in the buffer are known, measurement of Ca permits calculation of the rate of aqueous flow.
This method allows observation of changes in the rate of aqueous flow in an individual eye. For example, measurement of the concentration of tracer in the aqueous before and after administration of a drug is possible, allowing an eye to be used as its own control. Tracers used in this technique include '4C-labeled inulin [12] , which requires discrete sampling of the aqueous for detection of 14C in a liquid scintillation counter, and "3'I-labeled albumin [13, 14] , which permits constant monitoring of the concentration in the aqueous with a y detector.
Animals must be under general anesthesia during the course of the measurements since continuous cannulation of the eye is required. In addition, inflammation induced by the required invasive procedures limits the duration of experimentation to four to six hours for each eye studied.
TOPICAL APPLICATION OF FLUORESCEIN (CORNEAL DEPOT)
Langley and MacDonald [15] suggested that relative changes in aqueous flow could be determined by staining the cornea with fluorescein and measuring changes in its peak concentration in the aqueous. The first thorough quantitative discussion of how this method can be used to determine the absolute rate of aqueous flow was presented by Jones and Maurice [16] . In this report, they asserted that the rate of aqueous flow can be calculated by measuring the concentration of fluorescein in the aqueous over time. In addition, the determination of either the ratio of corneal fluorescein concentration to that in the aqueous or the total quantity of fluorescein in the eye is required. Their derivation, as adapted by Coakes and Brubaker [17] , requires the simultaneous solution of the linear differential equations which describe the rate of change of quantity of fluorescein in the anterior chamber: dma dma k m-(ka+ ko)ma [15] dt a a and in the corneal stroma: dmc d kamc + kma [16] where ma = the mass of fluorescein in the anterior chamber Mc = the mass of fluorescein in the cornea ka = the mass transfer coefficient from cornea to anterior chamber a = the mass transfer coefficient from anterior chamber to cornea ko = the mass transfer coefficient from aqueous to blood by bulk flow and diffusion The solutions take the form: ma = ye-at-ye-pt [17] m = Bet + (1 -S)e-' [18] where a, ,3, -y, and 8 are complex expressions consisting of combinations of the mass transfer coefficients and have no readily interpretable physical meaning. The solutions are exponential functions in which the second term decays more quickly than the first. In other words, while both terms contribute to changes in concentration of fluorescein early, only the a exponential influences the concentration at later times. The semilog plots of the concentration of fluorescein in the aqueous and the cornea, therefore, eventually become linear with slope -a (Fig. 1) . The semilog plot of the total mass of fluorescein in the eye also decreases with the same slope.
Jones and Maurice [16] proposed two methods to calculate the rate of aqueous flow based on the above equations. The first requires the measurement of anterior chamber fluorescence from the time the corneal fluorescein is instilled until some time later when the , term has decayed. Plotting the values on semilog paper, the slope of the linear portion of the curve is, as mentioned above, -a. The difference between the original curve and the extrapolated line with slope -a represents the I8 exponential term, and has slope -,13 (Fig. 1) . The values of the mass transfer coefficients can be calculated from the values of a, f, and the ratio of the concentration of fluorescein in the cornea to that in the aqueous on the linear portion of the curves. This ratio is constant once the ,B exponential has decayed and needs to be measured only once during the experiment.
Their second method requires several measurements of anterior chamber fluorescence a few hours after application of fluorescein once the 13 exponential has become small. The total mass of fluorescein in the eye, mi, is also measured at the same time 
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as one of the aqueous fluorescence measurements. Since it is assumed that the dye is lost from the cornea only by way of the aqueous, it follows that: dmi d= [19] where Ca is the anterior chamber fluorescence and Va is the volume of the anterior chamber. Dividing by m, leads to:
Since, after decay of the I exponential: _d [In(m,)] dt it follows that: atmt Vak= Ca [21] Ca and atmt f= Cam [22] wheref is the rate of aqueous flow and r is the fraction of fluorescein which leaves the eye by bulk flow, as opposed to diffusion. This value has been found to be approximately 0.80 following intracameral injection [10, 18] and approximately 0.86 following intravenous administration of fluorescein [18] .
These methods require a corneal depot of known quantity and distribution in order to obtain consistent results. This purpose can be accomplished either by instillation of a fluorescein solution into the conjunctival sac or by iontophoresis of a bolus of fluorescein into the corneal stroma. Topper et al. [19] showed that topical instillation of a fluorescein solution must be done several hours before any meaningful measurement of aqueous fluorescence can be made as it takes this length of time for uniform staining of the corneal stroma to occur. No delay was required for effective results after iontophoresis, as the procedure quickly provides a depot of fluorescein with sharply defined boundaries. Since the first method of Jones and Maurice requires early measurements of aqueous fluorescence, iontophoresis is required for this technique.
Diffusional loss of topically applied fluorescein from the anterior chamber cannot be determined by these techniques. The diffusional and flow components of the anterior chamber loss coefficient, k, cannot be separately evaluated. Thus, in investigating the effect of a drug or disease on the rate of aqueous flow, separate determination of a possible effect on the rate of diffusional loss of fluorescein must be undertaken.
An estimate of aqueous flow obtained by one of the corneal depot techniques is based on differences in fluorescence observed between at least two points in time. It represents, therefore, an average flow value between the end points rather than a measurement of flow at a discrete point in time. This fact becomes an important consideration in interpreting the results of experiments designed to detect changes in the rate of aqueous flow or to define maximum and minimum flow rates.
With the exception of the iontophoretic placement of the corneal fluorescein depot, these methods are completely noninvasive. As a result, they are useful not only in animal experimentation, but are ideal for clinical studies in humans.
VITREOUS DEPOT TECHNIQUE
A method of measuring aqueous humor flow in laboratory animals was devised by Johnson and Maurice [20] , using an intravitreal injection of FITC-dextran, which can presumably leave the eye only by diffusing across the interface between the vitreous and posterior chamber, and then exiting with the aqueous by bulk flow into the blood. After allowing several days for the tracer to become uniformly distributed in the vitreous and for the concentration of tracer in the aqueous to reach a maximum, the concentration of fluorescein in the anterior chamber reflects the rate of aqueous flow. As the dye diffuses into the posterior chamber, it is diluted to varying degrees, depending upon the aqueous flow rate. At high rates of flow the tracer is relatively dilute, while at low rates of flow it is more concentrated.
It is assumed that complete mixing occurs, that a steady state exists, i.e., that the rate of diffusion of FITC-dextran from the vitreous into the aqueous is equal to the rate at which it is leaving the anterior chamber by bulk flow, that the rate of aqueous flow is constant, and that the mass of FITC-dextran in the vitreous does not change appreciably during each measurement. Under these conditions, the rate of aqueous flow can be determined by the relationship:
kvm. = f -Ca [23] kvm[ Ca [24] where kv is the coefficient of diffusion of FITC-dextran from the vitreous into the aqueous and m, is the mass of FITC-dextran in the vitreous. The authors demon-strated that once the tracer is uniformly distributed and Ca has reached a maximum, the concentrations of FITC-dextran in the vitreous and aqueous decrease exponentially with the same rate constant, k,. The value of ki for a given species can be determined, therefore, by following the change of concentration of FITC-dextran in the aqueous or vitreous of a group of animals for several days. A semilog plot of this data is linear, with slope -kr. The rate of aqueous flow in an eye is determined by measuring Ca at some point in time, enucleating the eye, and measuring the quantity of FITC-dextran in the vitreous at the time the animal was sacrificed. Using the value of k,, m, at the time of the measurement can be determined, permitting calculation of the absolute rate of aqueous flow.
This technique has the advantage of allowing measurement of aqueous flow over extended periods of time since the tracer remains at readily detectable levels for up to two weeks, depending upon the sensitivity of the detector used. The steady-state assumption required for the flow calculation, however, can lead to errors if aqueous fluorescence measurements are made shortly after changes in flow rate. This problem, which will be discussed in detail below, is not unique to the vitreous depot technique; however, Gaul and Brubaker [21] found that this problem seems to be magnified in this technique, for reasons which were not clear. They compared the vitreous depot method with the second method of Jones and Maurice [16] in the detection of changes in aqueous flow rate after administration of acetazolamide and mannitol. During the hour after administration of either agent, the corneal depot technique showed a 50 percent decrease in aqueous flow rate, while no statistically significant difference was demonstrated by the vitreous depot method.
ENDOGENOUS TRACER SUBSTANCES Quantification of endogenously produced compounds which diffuse or are secreted from the blood into the aqueous can be used to calculate the rate of aqueous flow. Substances which enter the aqueous at constant or nearly constant rates behave as if there were a systemic "depot" and permit measurement of relative changes in aqueous flow rate by applying the same theory as that underlying the vitreous depot technique. Measurement of aqueous flare, which correlates with aqueous protein concentration, and determinations of aqueous ascorbate concentrations have been used in this way [22, 23, 24, 25, 26, 27 ]. It is not generally possible to make absolute flow measurements by these methods, however, as the rate of entrance of the tracer into the aqueous is difficult to determine.
MEASUREMENT OF PUPILLARY FLOW OF AQUEOUS HUMOR
Holm and Krakau [28] proposed a method to measure the flow of aqueous humor as it passes from the posterior to the anterior chamber through the pupil. This method uses fluorescein not as a tracer, but as a marker to delineate bubbles of aqueous humor as they emerge from the posterior chamber. By staining the aqueous in the anterior chamber with topically administered fluorescein, new aqueous passing through the pupil was found to form an unstained volume for up to 30 seconds before mixing began to occur. A photographic method of determination of the volume of the newly formed unstained aqueous was used to estimate the aqueous flow rate. By thoroughly mixing the aqueous through eye movements, the process could be repeated many times in a short period. Values obtained for rabbits were in the range of 1.5 to 3.8 ,ul/minute. Krakau later suggested a photoelectric method of quantifying the volume of unstained aqueous by measuring the decrease in fluorescence in a "cuvette" enclosing the pupil created by a suitably masked slit lamp fluorophotometer [29] . Since the intensity of fluorescence is directly proportional to the concentration of fluorescein, I(t)=I,-(k C-fCt) [25] where I(t) = the intensity of fluorescence at time t I = the intensity of fluorescence at time t = 0 (before any new aqueous is formed) f = the rate of aqueous flow, assumed to be constant C = the concentration of fluorescein in the thoroughly mixed aqueous k = a proportionality constant relating C and I After determining (k -C) by measuring the intensity of fluorescence in a known volume of well-mixed aqueous, flow can be determined by the equation. f = (t) [26] k -C * t [6 Although this method allows rapid measurements which can be quickly repeated, it is relatively sensitive to eye movements during the period of measurement, which cause mixing of newly formed aqueous with stained aqueous. In addition, the presence of a small pupil is required, necessitating topical treatment with pilocarpine before the period of measurement.
EFFECT OF VARIATION OF FLOW RATE ON THE RESULTS OF TRACER METHODS As noted above, methods of estimating the rate of aqueous flow assume this rate to be constant. Previous studies have demonstrated, however, that diurnal variations in aqueous flow occur in both rabbits [30] and humans [31] . To study the error introduced by this invalid assumption, I have developed the following compartmental model of a circadian system based on the vitreous depot technique. This model demonstrates the degree to which a continuously changing rate of aqueous flow can be expected to limit the ability of this particular method to determine flow rate accurately.
FITC-dextran was assumed to diffuse from the vitreous compartment into the aqueous compartment, then to leave the aqueous only by bulk flow. Back diffusion from the aqueous into the vitreous was assumed to be negligible, as Johnson and Maurice [20] have demonstrated that vitreous fluorescence levels average approximately 26 times greater than aqueous levels, using dextrans of high molecular weight. With these assumptions, the rate of diffusion of tracer into the aqueous is given by: (dM dt = k,M, e-k,t [27] and the rate of exit of tracer from the aqueous is given by:
dMt =C, C f(t) [28] [29] Assuming values of kI = 0.09 day-' [30] , M0 = 1 mg, and Vj = 0.25 ml, and letting the flow functionf(t) be the sinusoidal function with a range of 1.2 to 2.4 pdl/minute and a period of 24 hours, this differential equation was solved numerically for Ca using the Runge-Kutta fourth-order method [32] , programmed in Pascal on an Apple Macintosh computer, using a step size of 0.05 day. The function describing the concentration of FITC-dextran in the aqueous compartment under these conditions is shown in Fig. 2 . Substituting values of Ca given by this curve into equation 24, the equation used to calculate flow from aqueous fluorescence data by the intravitreal depot technique, calculated flow rates were compared with the "true" flow rates defined by the sinusoidal flow function (Fig. 3) .
The presence of a continuously changing rate of aqueous flow results in underestimation of the range of the circadian rhythm of aqueous flow and a shift in the phase of the rhythm. This result occurs because the changing concentration of FITCdextran lags significantly behind the changing rate of aqueous flow, due to the low rate of turnover of aqueous of about 1 percent per minute. Before the concentration of FITC-dextran reaches the level it would attain if the maximum flow rate were sustained, the flow rate begins to decrease. Although the above analysis is derived from the vitreous depot technique, these principles apply to all tracer methods and can affect their results in a similar fashion.
CONCLUSION
Each of the methods previously discussed has differences in precision of measurement, technical simplicity, invasiveness, and ease of mathematical treatment of data, making a particular technique more suitable for a given research protocol. There are several factors, however, which prevent any of these techniques from measuring with complete accuracy the total quantity of aqueous secreted by the ciliary epithelium. First, it must be remembered that not all of the aqueous leaves the eye by one particular route. While the majority of the fluid passes into the anterior chamber through the pupil and leaves the eye by bulk flow through the canal of Schlemm, the uveoscleral pathway acts as a second site of bulk outflow through which aqueous passes from the anterior chamber into the suprachoroidal space and from there through the sclera into periorbital tissues [33] . In addition, a small portion of aqueous never enters the anterior chamber, but leaves the eye posteriorly through the vitreous and retina. Tracer techniques are measurements only of anterior chamber turnover. The portion which exits the eye posteriorly cannot be measured by any currently available technique.
In addition, the mathematical treatment of data in the above methods assumes the rate of aqueous flow to be constant. Studies have shown, however, that a diurnal rhythm of aqueous flow exists both in rabbits [30] and in man [31] . As demonstrated by the model presented above, which assumes a continuously changing flow rate, the low rate of turnover of aqueous-approximately 1 percent per minute--causes the tracer concentration to lag behind changes in flow and results in some degree of inaccuracy, particularly in predicting maximum and minimum values.
Although such considerations limit the ability of these methods to quantify the rate of aqueous secretion precisely, relative changes in the rate of flow can still be readily detected. Alterations in aqueous flow induced by pharmacologic intervention or interruption of the eye's innervation can be clearly determined. Such measurements enable investigators to define the physiologic regulators of aqueous secretion and to help discover the mechanism of action of drugs of potential usefulness in the treatment of glaucoma.
